SCHEMBL13249803

SCHEMBL13249803

Cc1nc2c(c(=O)n1C(c1ccccc1)c1ccccc1)CCN(C(=O)Oc1ccc([N+](=O)[O-])cc1)C2

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.56
FAAH O00519 4/20 0.51
TRPV1 Q8NER1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13328933 0.93 MGLL (0.56) MGLLFAAHTRPV1
SCHEMBL13249795 0.91 MGLL (0.47) MGLLFAAHTRPV1
SCHEMBL13249797 0.90 MGLL (0.42) MGLLFAAHTRPV1
SCHEMBL13249800 0.89 MGLL (0.42) MGLLFAAHTRPV1
SCHEMBL13249801 0.88 MGLL (0.41) MGLLFAAHTRPV1
SCHEMBL13249814 0.88 MGLL (0.41) MGLLFAAHTRPV1
SCHEMBL13249804 0.88 MGLL (0.41) MGLLFAAHTRPV1
SCHEMBL13249807 0.87 MGLL (0.40) MGLL
SCHEMBL13250415 0.87 MGLL (0.40) MGLLFAAHTRPV1
SCHEMBL13249945 0.86 LIPE (0.43) MGLLFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190687-A1 PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190687-A1 PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF GPR119, GCGR, GPR65 MGLL 882/4885FAAH 1561/4885TRPV1 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.